Introduction
The 2012 Health and Social Care Act places duties on NHS England and Clinical Commissioning Groups to 'have regard to the need to reduce inequalities between patients with respect to their ability to access health services'. 1 Following the NHS Plan in 2000, private providers of healthcare services have expanded rapidly. In 2003, privately owned independent sector treatment centres were commissioned to treat NHS patients, focussing on high-volume elective surgical procedures, despite concerns about cost, quality and the 'cherry picking' of healthier patients over those with more complex health problems. [2] [3] [4] [5] The 'free choice' agenda 6 allowed any private provider of healthcare to provide elective care to any NHS patient, provided they had registered with the relevant body. 7 Commercial tendering of NHS services is now virtually compulsory. 8 Between April 2013 and August 2014, a third of contracts to provide NHS clinical services were awarded to the private sector, and between 2015 and 2016, NHS England expenditure on private sector provision of secondary care services reached £8.7 billion, representing 7.7% of total NHS expenditure in 2015/ 2016.
9,10
Elective hip arthroplasty is a common elective procedure with demonstrable improvements in quality of life. [11] [12] [13] In 2017, over one-third of NHS-funded elective hip arthroplasties were performed by the private sector.
14 Variations in elective hip arthroplasty rates are well documented, with female and older patients and those living in the most deprived areas less likely to receive treatment relative to need. 
Statistical analysis
Numbers of elective and emergency hip arthroplasties and crude and age standardised rates per 100,000 population with 95% confidence intervals (CI) were 
Measures of inequality
Absolute and relative differences in age-standardised hip arthroplasties rates between the 20% least deprived and the 20% most deprived population for each year of data from 2004/2005 onwards were calculated. We examined trends in absolute and relative differences over time by performing simple linear regression, using least squares methods. We calculated slope of index inequality (SII) and relative slope of index inequality (RII) for each year from 2004/2005 onwards to measure the difference in age-standardised rates by taking into account the inequality across all adjacent quintiles of relative deprivation, rather than focusing only on the extremes, using previously developed techniques. 21, 22 For each year, the age-standardised rates for each IMD quintile were ranked and weighted according to the distribution in the population. The slope index of inequality (SII) is the linear regression coefficient that shows the relation between the age-standardised rates in each IMD quintile and the cumulative fraction of population ranked by deprivation. The SII can be interpreted as the absolute effect on treatment rates of moving from the lowest socioeconomic level through to the highest and has the advantage over more simple measures of inequalities by making use of all the data. 23 As SII is sensitive to the mean arthroplasty rate of the population, we also calculate the relative index of inequality by dividing the SII by the mean rate in the population. We examined trends in SII and RII over time by performing simple linear regression.
All analysis was performed using Stata version 14 and Microsoft excel. All significance testing is to p < 0.05.
Patient and public involvement
No patients or public were involved in the design of this study. The age-sex distribution of those undergoing elective arthroplasties differed by provider ( Figure 2 , Table 2 ). Overall, the proportions of younger boys/ men (0-59 years) and older women (>75 years) were higher among NHS providers compared with private Age-standardised rates were significantly higher in IMD 4 compared to IMD 1, 2, 3 and 5 for all years except 2012/2013, when adjusted rates for both IMD 4 and 5 were similar 164.6 (95%CI 162.1-167) and 162.5 (95% CI 160-164.9) and both significantly higher than IMD 1, 2 and 3. The highest rates year on year occurred in IMD 4 and IMD 5, significantly higher than the more deprived quintiles (IMD 1, 2 and 3) .
Results

General trends in NHS-
In 2004/2005, there was no significant difference in adjusted treatment rates between IMD 1 (2.1 per 100,000; 95%CI 1.8-2.5) and IMD 5 (2.2 per 100,000; 95%CI 1.9-2.5); this widened yearly and by 2012/2013, the rate for IMD 5 (35.4 per 100,000; 95%CI 34.3-36.5) was significantly higher than that for IMD 1 (25.2 per 100,000; 95%CI 24.1-26.4).
Trends in inequality in hip arthroplasty rates between 2004/2005 and 2012/2013
Trends gradients were positive for all measures of inequality (except relative difference), suggesting a widening of inequalities over time; however, none were statistically significant (p > 0.05) in any measure of inequality (absolute, relative difference, and slope and relative slope of index inequality) ( Figure 5 , Table 5 ). This was due to the protective and buffering effects of NHS provision which still remained the predominant provider of elective hip arthroplasties during the study period.
Discussion
Main findings
Our findings are similar to the findings of a Scottish study where increasing private sector provision was associated with a fall in NHS provision. 19 Since 2015, the Scottish government policy has been to 'effectively eliminate use of the private sector for planned care' 24 in England the Department of Health continues to adopt policies of outsourcing of healthcare provision. 25 
Strengths and limitations of study
This is the first study in England examining the effects of NHS funding of private provision on NHS direct provision and inequalities in access, using treatment rates by provider type.
Limitations include lack of adjustment for need which is highest among more deprived groups 16 ; thus, differences observed between socioeconomic groups will underestimate true inequities in treatment provision.
Second, the extent to which privately funded patients are receiving hip arthroplasty is unknown as Hospital Episode Statistics data do not capture data on privately funded and performed hip arthroplasties; it is difficult to estimate the impact on inequalities. Derived estimates from private providers who perform only privately funded hip arthroplasties suggest the number of privately There is evidence that individuals who would have undergone privately funded hip arthroplasty transferred to NHS funding, as waiting times reduced. 26 Despite this substitution between private and NHS-funded joint replacements, we still found rates of NHS-funded hip arthroplasties were consistently highest among the second most affluent quintile. The size of any substitution effect on inequality is difficult to quantify. Research by Mindell et al. found private-funded coronary intervention was inversely related to need and exacerbated inequalities. 27 Third, we were not able to examine where in the care pathway inequity occurs; GPs may be less likely to refer older, ethnic minorities and less-educated patients; or geographic location of private providers combined with risk selection may result in some individuals being less likely to be treated by private providers. 2, 4, [28] [29] [30] [31] We found private providers favoured less extremes of ages compared to NHS providers. Those individuals aged <59 years for boys/men and >75 years for women requiring elective hip arthroplasty may represent more complex arthroplasties or associated co-morbidities that are excluded by private providers.
Implication of findings
The large and sustained increases in NHS-funded elective hip arthroplasties between 1997/1998 and 2007/2008 was delivered using NHS providers. This period coincides with large increases in NHS funding, from £59 billion in 1997/1998 to £110 billion in 2007/ 2008 (at 2010/2011 prices) 32 demonstrating the NHS ability to increase capacity when supported by sufficient funding.
Previous analysis by Cooper et al. found no substantial widening of inequalities in waiting times by socioeconomic group during this period. 18 This is likely due to outsourcing still being in its infancy, contributing to < 5% of NHS-funded elective arthroplasties and large increases in NHS funding and provision.
In 2017, one in three of all NHS-funded elective hip arthroplasties are performed in the private sector.
14 If the trends shown here continue, whereby private provision substitutes for NHS direct provision with risk selection favouring less deprived patients, then widening inequalities are likely.
The Health and Social Care Act 2012 places a duty on Clinical Commissioning Groups to 'reduce inequalities between patients with respect to their ability to access health services'. Our findings suggest Clinical Commissioning Groups should immediately reassess private sector contracting, undertake further research on its impact from 2012/2013 onwards on inequalities and consider and monitor the impact both on direct NHS provision and inequalities. Ethics approval: Ethical approval was not required as data were anonymised and published in aggregate form.
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